Zephyrnet Logo

Tag: T-Cells

Singaporeans are Armouring Up Against Viral Infections and Diseases with LAC’s Immunity Arsenal

SINGAPORE, Mar 4, 2024 - (ACN Newswire) - The importance of a robust immune system cannot be overstated—it serves as our body's frontline defence...

Top News

‘Useless’ Organ That Doctors Often Remove May Actually Fight Cancer

There’s a small fatty gland that sits behind your sternum and is often said to be ‘useless’ in adulthood.A recent retrospective study, however, suggests...

Scientists Discover a Genetic Variant That Seems to Limit HIV Infection

Scientists Discover a Genetic Variant That Seems to Limit HIV Infection Posted on August 14, 2023 Updated on August 14, 2023 ...

Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells

TOKYO, Aug 08, 2023 - (JCN Newswire) - Aichi Cancer Center and NEC Corporation's research group with Gifu University, Toyama University and Kitasato University...

CAR T, a Revolutionary ‘Living Drug’, Shows Promise in Combating Severe Medical Conditions

CAR T, a Revolutionary 'Living Drug', Shows Promise in Combating Severe Medical ConditionsIn recent years, a groundbreaking therapy known as CAR T-cell therapy, or...

Five biotech companies making a name for themselves in Vancouver

British Columbia has become a major hub of biotech innovation within the last decade or more, and the popular coastal city of Vancouver is...

First rCAR-T therapy autoimmunity trial shows potential

A novel RNA CAR-T cell therapy demonstrated long-term clinical benefit for most generalised myasthenia gravis (gMG) patients in a landmark study. Study data from a...

Dr. James Field on Breaking the ‘Cognition Barrier’ in Antibody Discovery with AI and Robotics

We're fortunate to speak with Dr. James Field, founder and CEO of LabGenius, a leading machine learning (ML)-driven protein engineering company headquartered in London....

Valo Therapeutics and Texcell Announce Research Collaboration to Evaluate Immune Responses to PeptiCRAd-1 in Phase I Clinical Study | BioSpace

HELSINKI, Finland and EVRY, France, June 13, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapies for cancer, announces...

Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours – Nature Nanotechnology

Hou, A. J., Chen, L. C. & Chen, Y. Y. Navigating CAR-T cells through the solid-tumor microenvironment. Nat. Rev. Drug Discov. 20, 531–550 (2021).Article ...

Thanks to generative AI, catching fraud science is going to be this much harder

Feature Generative AI poses interesting challenges for academic publishers tackling fraud in science papers as the technology shows the potential to fool human peer...

Can We Program Our Cells?

IntroductionMaking living cells blink fluorescently like party lights may sound frivolous. But the demonstration that it’s possible could be a step toward someday programming...

Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics

Melero, I., Castanon, E., Alvarez, M., Champiat, S. & Marabelle, A. Intratumoural administration and tumour tissue targeting of cancer immunotherapies. Nat. Rev. Clin. Oncol....

Latest Intelligence

spot_img
spot_img